Randomized Study of Fluoxetine in Children and Adolescents With Autism

Completed · Not applicable

Conditions studied: Autism

In brief

OBJECTIVES: I. Evaluate the efficacy of fluoxetine on social and language deficits, global severity and compulsive dimensions of children and adolescents with autism. II. Assess the effectiveness of this treatment regimen on neurocognitive deficits in this patient population. III. Compare the baseline compulsive severity and treatment outcome in these patients.

Key facts

Study ID

NCT00004486

Run by

Icahn School of Medicine at Mount Sinai

People needed

45

Starts

1998-09-01

Expected to finish

2002-12-01

Last updated by the study team

2015-03-25

Who can join

Age: 5 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

• New York University Medical Center — New York, New York, United States
• Mount Sinai School of Medicine — New York, New York, United States
• Albert Einstein College of Medicine — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.